GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 11, 2024
Displaying entries 16501 - 16550 of 40384 in total
PDB ID UniProt ID Title ▼ Descriptor
5AVW C4IX13 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 16.5 min
5AVW Q70Q12 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 16.5 min
5AW3 Q4H132 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 100 min
5AW3 C4IX13 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 100 min
5AW3 Q70Q12 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 100 min
5AVR Q4H132 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min
5AVR C4IX13 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min
5AVR Q70Q12 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min
5AVQ Q4H132 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 0.75 min.
5AVQ C4IX13 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 0.75 min.
5AVQ Q70Q12 Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 0.75 min.
5AW6 Q4H132 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 5.5 min
5AW6 C4IX13 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 5.5 min
5AW6 Q70Q12 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 5.5 min
5AW5 Q4H132 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 2.2 min
5AW5 C4IX13 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 2.2 min
5AW5 Q70Q12 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 2.2 min
5AW7 Q4H132 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 11.3 min
5AW7 C4IX13 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 11.3 min
5AW7 Q70Q12 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 11.3 min
5AW4 Q4H132 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min
5AW4 C4IX13 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min
5AW4 Q70Q12 Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min
5AW8 Q4H132 Kinetics by X-ray crystallography: E2.MgF42-.2RB+ crystal
5AW8 C4IX13 Kinetics by X-ray crystallography: E2.MgF42-.2RB+ crystal
5AW8 Q70Q12 Kinetics by X-ray crystallography: E2.MgF42-.2RB+ crystal
1XL0 P00489 Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
1XL1 P00489 Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
8B70 P96589 KimA from B. subtilis with nucleotide second-messenger c-di-AMP bound
5X3K D2PPM7 Kfla1895 D451A mutant in complex with isomaltose
5X3J D2PPM7 Kfla1895 D451A mutant in complex with cyclobis-(1->6)-alpha-nigerosyl
6F8N A8GFD6 Key residues affecting transglycosylation activity in family 18 chitinases - Insights into donor and acceptor subsites
2G1N P00797 Ketopiperazine-based renin inhibitors: Optimization of the "C" ring
2G1R P00797 Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring
2G1S P00797 Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring
2G1O P00797 Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2G1Y P00797 Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
2G22 P00797 Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring
4PR7 Q934G3 KdgM porin in complex with disordered oligogalacturonate
7F57 P42260 Kainate-bound GluK2-1xNeto2 complex, at the desensitized state
7F57 C6K2K4 Kainate-bound GluK2-1xNeto2 complex, at the desensitized state
9B38 P42260 Kainate receptor GluK2 in complex with agonist glutamate with pseudo 4-fold symmetrical ligand-binding domain layer
9B39 P42260 Kainate receptor GluK2 in complex with agonist glutamate with asymmetric ligand-binding domain layer
9BL3 I3ZN84 KIR3DL1*114 in complex with HLA-B*57:03 presenting the AW10 peptide
9BL3 P61769 KIR3DL1*114 in complex with HLA-B*57:03 presenting the AW10 peptide
9BL3 P35221 KIR3DL1*114 in complex with HLA-B*57:03 presenting the AW10 peptide
9BL3 A0A5J6VN80 KIR3DL1*114 in complex with HLA-B*57:03 presenting the AW10 peptide
9BL6 A0A411J078 KIR3DL1*114 in complex with HLA-A*24:02 presenting the TW9 peptide
9BL6 P61769 KIR3DL1*114 in complex with HLA-A*24:02 presenting the TW9 peptide
9BL6 Q809Q3 KIR3DL1*114 in complex with HLA-A*24:02 presenting the TW9 peptide

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024